Myostatin as a Biomarker for Diagnosis or Prognosis of Frailty and Sarcopenia: Current Knowledge.
["Arrieta, Haritz", "Rodriguez-Larrad, Ana", "Irazusta, Jon"]
Gerontology 2019
Myostatin as a Biomarker for Diagnosis or Prognosis of Frailty and Sarcopenia: Current Knowledge. Arrieta H(1), Rodriguez-Larrad A(2), Irazusta J(2).